Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2596 to 2610 of 9007 results

  1. Doxorubicin nanoparticles for previously treated advanced hepatocellular carcinoma [ID1314]

    In development Reference number: GID-TA10251 Expected publication date: TBC

  2. Veliparib with carboplatin and paclitaxel for untreated non-squamous non-small-cell lung cancer [ID1277]

    In development Reference number: GID-TA10248 Expected publication date: TBC

  3. Sacituzumab tirumotecan for treating advanced or metastatic gastric, gastro-oesophageal junction or oesophageal adenocarcinoma after 2 or more treatment lines [ID6723]

    Awaiting development Reference number: GID-TA11932 Expected publication date: TBC

  4. Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA)

    Topic prioritisation

  5. NeuroSAFE for Intra-operative frozen section evaluation of neurovascular bundle adjacent prostate capsule during radical prostatectomy

    Topic prioritisation

  6. Orbital atherectomy for calcified coronary artery disease

    Topic prioritisation

  7. Multi-vessel minimal access coronary artery surgery for multi-vessel coronary artery disease

    Topic prioritisation

  8. MRI guided transurethral high intensity ultrasound ablation of the prostate

    Topic prioritisation

  9. Coronary venous arterialisation in patients with refractory angina

    Topic prioritisation

  10. EchoLaser percutaneous laser ablation treatment for patients with neck lesions

    Topic prioritisation

  11. Pancreas SABR

    Topic prioritisation

  12. Stockholm3 blood test for prostate cancer, (MT734),

    Topic prioritisation

  13. Spartan RX point-of-care CYP2C19 test

    Topic prioritisation

  14. Subcutaneous nivolumab for treating advanced renal cell carcinoma after systemic treatment TSID 12008

    Topic prioritisation